M. Mornet

461 total citations
12 papers, 329 citations indexed

About

M. Mornet is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, M. Mornet has authored 12 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in M. Mornet's work include Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). M. Mornet is often cited by papers focused on Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). M. Mornet collaborates with scholars based in France, United Kingdom and Réunion. M. Mornet's co-authors include B Lebeau, Claude Chastang, Étienne Lemarié, Frédérique Capron, J.-M. Bréchot, Bertrand Dautzenberg, L Jeannin, Élodie Masseret, Bertrand Maury and Pierre Dupont and has published in prestigious journals such as Cancer, Journal of Clinical Microbiology and Annals of Oncology.

In The Last Decade

M. Mornet

11 papers receiving 317 citations

Peers

M. Mornet

ONCOL

PRM

CCM

Nobutaka Tasaka Japan

Sari Nakao Japan

Peter van Balen Netherlands

Gary Woods United States

Ximena Sánchez United States

Debra J. Endean United States

Cherie Cameron Canada

Paulino Tallón de Lara United States

Linda Berberian United States

Jana Babatz Germany

Nobutaka Tasaka Japan

M. Mornet

53 ×0.4

75 ×0.8

ONCOL

41 ×0.5

PRM

43 ×0.6

CCM

73 ×1.0

Citations per year, relative to M. Mornet M. Mornet (= 1×) peers Nobutaka Tasaka

Countries citing papers authored by M. Mornet

Since Specialization

Citations

This map shows the geographic impact of M. Mornet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mornet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mornet more than expected).

Fields of papers citing papers by M. Mornet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Mornet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mornet. The network helps show where M. Mornet may publish in the future.

Co-authorship network of co-authors of M. Mornet

This figure shows the co-authorship network connecting the top 25 collaborators of M. Mornet. A scholar is included among the top collaborators of M. Mornet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Mornet. M. Mornet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Chavaillon, J.-M., P. David, Martin Fortin, et al.. (2010). Mortalité intrahospitalière au cours des exacerbations aiguës de BPCO. Étude EABPCO-CPHG du Collège des pneumologues des hôpitaux généraux (CPHG). Revue des Maladies Respiratoires. 27(7). 709–716. 6 indexed citations

Piquet, J., J.-M. Chavaillon, P. David, et al.. (2009). Caractéristiques et prise en charge des exacerbations aiguës de BPCO hospitalisées. Étude EABPCO–CPHG du Collège des pneumologues des hôpitaux généraux. Revue des Maladies Respiratoires. 27(1). 19–29. 10 indexed citations

Noël, Christophe, Thanh Haï Duong, M. Mornet, et al.. (2009). Molecular Characterization of a New Tetratrichomonas Species in a Patient with Empyema. Journal of Clinical Microbiology. 47(7). 2336–2339. 32 indexed citations

Douillard, Jean‐Yves, R. Gervais, G Dabouis, et al.. (2004). Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study. Annals of Oncology. 16(1). 81–89. 31 indexed citations

Douillard, Jean‐Yves, R. Gervais, H. Lacroix, et al.. (2000). Preliminary results of a randomized study on first and second line chemotherapy strategy in stage IV non-small cell lung cancer (NSCLC), assessing docetaxel (D) and cisplatin (C) until progressive disease (PD) then vinorelbine (V) versus V-C until PD then D. Lung Cancer. 29(1). 91–92. 2 indexed citations

Quoix, Élisabeth, B Lebeau, P. Jacoulet, et al.. (2000). Preliminary results of a randomized study comparing the efficacy of 2 doses of docetaxel 100 mg/m2/3 weeks vs 75 mg/m2/3 weeks in treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of a previous cis-platin based chemotherapy. Lung Cancer. 29(1). 60–60. 1 indexed citations

Urban, T., Claude Chastang, L Jeannin, et al.. (1999). Standard combination versus alternating chemotherapy in small cell lung cancer. Lung Cancer. 25(2). 105–113. 15 indexed citations

Lebeau, B, Claude Chastang, J.-M. Bréchot, et al.. (1994). Subcutaneous heparin treatment increases survival in small cell lung cancer. Cancer. 74(1). 38–45. 225 indexed citations

Mornet, M., et al.. (1992). [Diarrhea caused by Cyclo 3 fort].. PubMed. 46(3). 254–254. 1 indexed citations

10.

Chérìn, P., J.C. Pietté, O Blétry, et al.. (1990). Histocytome fibreux malin des tissus mous : présentations atypiques. La Revue de Médecine Interne. 11(2). 121–128.

11.

Mornet, M., et al.. (1987). [Isolated angiocholitic form of congenital hepatic fibrosis].. PubMed. 11(12). 911–2. 1 indexed citations

12.

Mornet, M., et al.. (1986). [Orf: recontamination 8 months after the original infection. Review of the literature apropos of a case].. PubMed. 113(11). 1065–76. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact